The role of dsRNA A-to-I editing catalyzed by ADAR family enzymes in the pathogeneses

The process of adenosine deaminase (ADAR)-catalyzed double-stranded RNA (dsRNA) Adenosine-to-Inosine (A-to-I) editing is essential for the correction of pathogenic mutagenesis, as well as the regulation of gene expression and protein function in mammals. The significance of dsRNA A-to-I editing in d...

Full description

Saved in:
Bibliographic Details
Main Authors: Wanqing Liu, Yufan Wu, Tong Zhang, Xiaobo Sun, Dean Guo, Zizhao Yang
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:RNA Biology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/15476286.2024.2414156
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850263340719276032
author Wanqing Liu
Yufan Wu
Tong Zhang
Xiaobo Sun
Dean Guo
Zizhao Yang
author_facet Wanqing Liu
Yufan Wu
Tong Zhang
Xiaobo Sun
Dean Guo
Zizhao Yang
author_sort Wanqing Liu
collection DOAJ
description The process of adenosine deaminase (ADAR)-catalyzed double-stranded RNA (dsRNA) Adenosine-to-Inosine (A-to-I) editing is essential for the correction of pathogenic mutagenesis, as well as the regulation of gene expression and protein function in mammals. The significance of dsRNA A-to-I editing in disease development and occurrence is explored using inferential statistics and cluster analyses to investigate the enzymes involved in dsRNA editing that can catalyze editing sites across multiple biomarkers. This editing process, which occurs in coding or non-coding regions, has the potential to activate abnormal signalling pathways that contributes to disease pathogenesis. Notably, the ADAR family enzymes play a crucial role in initiating the editing process. ADAR1 is upregulated in most diseases as an oncogene during tumorigenesis, whereas ADAR2 typically acts as a tumour suppressor. Furthermore, this review also provides an overview of small molecular inhibitors that disrupt the expression of ADAR enzymes. These inhibitors not only counteract tumorigenicity but also alleviate autoimmune disorders, neurological neurodegenerative symptoms, and metabolic diseases associated with aberrant dsRNA A-to-I editing processes. In summary, this comprehensive review offers detailed insights into the involvement of dsRNA A-to-I editing in disease pathogenesis and highlights the potential therapeutic roles for related small molecular inhibitors. These scientific findings will undoubtedly contribute to the advancement of personalized medicine based on dsRNA A-to-I editing.
format Article
id doaj-art-4a1b72ecf5134bf284860c9dc7d95ab4
institution OA Journals
issn 1547-6286
1555-8584
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series RNA Biology
spelling doaj-art-4a1b72ecf5134bf284860c9dc7d95ab42025-08-20T01:54:58ZengTaylor & Francis GroupRNA Biology1547-62861555-85842024-12-012111128114510.1080/15476286.2024.2414156The role of dsRNA A-to-I editing catalyzed by ADAR family enzymes in the pathogenesesWanqing Liu0Yufan Wu1Tong Zhang2Xiaobo Sun3Dean Guo4Zizhao Yang5School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaBeijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, ChinaShanghai Research Center for Modernization of Traditional Chinese Medicine, National Engineering Research Center of TCM Standardization Technology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, ChinaSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaThe process of adenosine deaminase (ADAR)-catalyzed double-stranded RNA (dsRNA) Adenosine-to-Inosine (A-to-I) editing is essential for the correction of pathogenic mutagenesis, as well as the regulation of gene expression and protein function in mammals. The significance of dsRNA A-to-I editing in disease development and occurrence is explored using inferential statistics and cluster analyses to investigate the enzymes involved in dsRNA editing that can catalyze editing sites across multiple biomarkers. This editing process, which occurs in coding or non-coding regions, has the potential to activate abnormal signalling pathways that contributes to disease pathogenesis. Notably, the ADAR family enzymes play a crucial role in initiating the editing process. ADAR1 is upregulated in most diseases as an oncogene during tumorigenesis, whereas ADAR2 typically acts as a tumour suppressor. Furthermore, this review also provides an overview of small molecular inhibitors that disrupt the expression of ADAR enzymes. These inhibitors not only counteract tumorigenicity but also alleviate autoimmune disorders, neurological neurodegenerative symptoms, and metabolic diseases associated with aberrant dsRNA A-to-I editing processes. In summary, this comprehensive review offers detailed insights into the involvement of dsRNA A-to-I editing in disease pathogenesis and highlights the potential therapeutic roles for related small molecular inhibitors. These scientific findings will undoubtedly contribute to the advancement of personalized medicine based on dsRNA A-to-I editing.https://www.tandfonline.com/doi/10.1080/15476286.2024.2414156Double Stranded RNA (dsRNA) Adenosine-to-Inosine (A-to-I) EditingAdenosine Deaminases (ADAR) EnzymePathogenesisRNA ModificationTumorigenicity
spellingShingle Wanqing Liu
Yufan Wu
Tong Zhang
Xiaobo Sun
Dean Guo
Zizhao Yang
The role of dsRNA A-to-I editing catalyzed by ADAR family enzymes in the pathogeneses
RNA Biology
Double Stranded RNA (dsRNA) Adenosine-to-Inosine (A-to-I) Editing
Adenosine Deaminases (ADAR) Enzyme
Pathogenesis
RNA Modification
Tumorigenicity
title The role of dsRNA A-to-I editing catalyzed by ADAR family enzymes in the pathogeneses
title_full The role of dsRNA A-to-I editing catalyzed by ADAR family enzymes in the pathogeneses
title_fullStr The role of dsRNA A-to-I editing catalyzed by ADAR family enzymes in the pathogeneses
title_full_unstemmed The role of dsRNA A-to-I editing catalyzed by ADAR family enzymes in the pathogeneses
title_short The role of dsRNA A-to-I editing catalyzed by ADAR family enzymes in the pathogeneses
title_sort role of dsrna a to i editing catalyzed by adar family enzymes in the pathogeneses
topic Double Stranded RNA (dsRNA) Adenosine-to-Inosine (A-to-I) Editing
Adenosine Deaminases (ADAR) Enzyme
Pathogenesis
RNA Modification
Tumorigenicity
url https://www.tandfonline.com/doi/10.1080/15476286.2024.2414156
work_keys_str_mv AT wanqingliu theroleofdsrnaatoieditingcatalyzedbyadarfamilyenzymesinthepathogeneses
AT yufanwu theroleofdsrnaatoieditingcatalyzedbyadarfamilyenzymesinthepathogeneses
AT tongzhang theroleofdsrnaatoieditingcatalyzedbyadarfamilyenzymesinthepathogeneses
AT xiaobosun theroleofdsrnaatoieditingcatalyzedbyadarfamilyenzymesinthepathogeneses
AT deanguo theroleofdsrnaatoieditingcatalyzedbyadarfamilyenzymesinthepathogeneses
AT zizhaoyang theroleofdsrnaatoieditingcatalyzedbyadarfamilyenzymesinthepathogeneses
AT wanqingliu roleofdsrnaatoieditingcatalyzedbyadarfamilyenzymesinthepathogeneses
AT yufanwu roleofdsrnaatoieditingcatalyzedbyadarfamilyenzymesinthepathogeneses
AT tongzhang roleofdsrnaatoieditingcatalyzedbyadarfamilyenzymesinthepathogeneses
AT xiaobosun roleofdsrnaatoieditingcatalyzedbyadarfamilyenzymesinthepathogeneses
AT deanguo roleofdsrnaatoieditingcatalyzedbyadarfamilyenzymesinthepathogeneses
AT zizhaoyang roleofdsrnaatoieditingcatalyzedbyadarfamilyenzymesinthepathogeneses